Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

ClinicalTrials.gov ID: NCT03080883

Public ClinicalTrials.gov record NCT03080883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 5:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six Months of Anticoagulation Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related venous thrombosis in cancer patients who have completed anticoagulation therapy. Apixaban may help in prevention by blocking some of the enzymes needed for venous thrombosis.

Study identification

NCT ID
NCT03080883
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
370 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2017 (Actual)
Primary completion
Jun 7, 2022 (Actual)
Completion
May 9, 2025 (Actual)
Last update posted
May 18, 2025

2017 – 2025

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Mayo Clinic in Arizona Scottsdale Arizona 85259 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Mayo Clinic in Florida Jacksonville Florida 32224-9980 —
Cleveland Clinic-Weston Weston Florida 33331 —
Northwestern University Chicago Illinois 60611 —
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 —
Illinois CancerCare-Peoria Peoria Illinois 61615 —
Carle Cancer Center Urbana Illinois 61801 —
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 —
Cancer Center of Kansas - Wichita Wichita Kansas 67214 —
Saint Elizabeth Medical Center South Edgewood Kentucky 41017 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 —
Mayo Clinic in Rochester Rochester Minnesota 55905 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Washington University School of Medicine St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
New Hampshire Oncology Hematology PA-Hooksett Hooksett New Hampshire 03106 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Solinsky Center for Cancer Care Manchester New Hampshire 03103 —
Montefiore Medical Center - Moses Campus The Bronx New York 10467 —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst North Carolina 28374 —
Altru Cancer Center Grand Forks North Dakota 58201 —
University of Washington Medical Center - Montlake Seattle Washington 98195 —
Mayo Clinic Health System-Eau Claire Clinic Eau Claire Wisconsin 54701 —
Dean Hematology and Oncology Clinic Madison Wisconsin 53717 —
Marshfield Medical Center-Marshfield Marshfield Wisconsin 54449 —
Froedtert and the Medical College of Wisconsin LAPS Milwaukee Wisconsin 53226 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03080883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03080883 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →